Role of heavy sweating for ST-segment elevation myocardial infarction: analysis of the China Acute Myocardial Infarction registry
- PMID: 40394465
- PMCID: PMC12093881
- DOI: 10.1186/s12872-025-04840-3
Role of heavy sweating for ST-segment elevation myocardial infarction: analysis of the China Acute Myocardial Infarction registry
Abstract
Background: Sweating in individuals with suspected cardiac chest pain indicates a greater risk of experiencing ST-segment elevation myocardial infarction (STEMI). Nevertheless, the relationship between sweating and clinical outcomes remains inadequately explored.
Methods: From 2013 through 2016, 19112 patients with STEMI enrolled in the China Acute Myocardial Infarction registry. Heavy sweating was evaluated on admission and usually judged by dampen clothing. Thrombolysis in Myocardial Infarction (TIMI) flow and ST-segment resolution (STR) were used to evaluated the myocardial reperfusion after primary percutaneous myocardial infarction (PCI). The primary outcome was all-cause death during hospitalization and at 24 months.
Results: Thirteen thousand, four hundred twenty-two patients (70.2%) presented heavy sweating, that was associated with age < 65 years, severe chest pain, current smoking status, and heart rates < 100 bpm on admission. Heavy sweating group was more likely to achieve primary PCI (44.7% vs 32.9%) but shown similar rates of post-PCI TIMI 3 flow (95.5% vs 94.1%) and STR ≥ 50% (79.8% vs 78.2%). After multivariable analysis, heavy sweating was significantly linked to lower in-hospital (5.9% vs 8.6%, odds ratio [OR]: 0.81, 95% confidence interval [CI]: 0.72-0.92) and 24-month mortality (11.0% vs 17.2%, hazard ratio [HR]: 0.75, 95% CI: 0.69-0.82). Even among patients undergoing primary PCI who achieved successful myocardial reperfusion, this short- (2.5% vs 4.2%, OR: 0.60, 95% CI: 0.45-0.80) and long-term (5.9% vs 8.7%, HR: 0.68, 95% CI: 0.56-0.83) prognostic significance remained robust.
Conclusions: For STEMI, the presence of heavy sweating was associated with lower mortality regardless of successful primary PCI, which highlight the potential for early risk stratification based on the sweating presentation.
Trial registration: https//www.
Clinicaltrials: gov. Unique identifier: NCT01874691. Registered 11/06/2013.
Keywords: Myocardial infarction; Outcome; Sweating; Symptom.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was approved by Ethics Committee of Fuwai Cardiovascular Hospital (No. 431). Written informed consent was obtained from eligible patients. The study was conducted in compliance with the Declaration of Helsinki. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
10-Year Outcomes of Deferred or Conventional Stent Implantation in Patients With STEMI (DANAMI-3-DEFER).Circ Cardiovasc Interv. 2025 Jun;18(6):e015369. doi: 10.1161/CIRCINTERVENTIONS.125.015369. Epub 2025 May 20. Circ Cardiovasc Interv. 2025. PMID: 40391569 Free PMC article. Clinical Trial.
-
Assessing angiographic results of saline autotransfusion and thrombus aspiration in STEMI patients.Future Cardiol. 2025 Mar;21(4):237-243. doi: 10.1080/14796678.2025.2472581. Epub 2025 Mar 4. Future Cardiol. 2025. PMID: 40035694
-
Analysis of inter-hospital transfer on clinical outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A secondary analysis of the BRIGHT-4 trial.PLoS Med. 2025 Jul 23;22(7):e1004679. doi: 10.1371/journal.pmed.1004679. eCollection 2025 Jul. PLoS Med. 2025. PMID: 40700454 Free PMC article. Clinical Trial.
-
Comparison of Reperfusion Strategies for ST-Segment-Elevation Myocardial Infarction: A Multivariate Network Meta-analysis.J Am Heart Assoc. 2020 Jun 16;9(12):e015186. doi: 10.1161/JAHA.119.015186. Epub 2020 Jun 5. J Am Heart Assoc. 2020. PMID: 32500800 Free PMC article.
-
Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease.Cochrane Database Syst Rev. 2017 May 3;5(5):CD011986. doi: 10.1002/14651858.CD011986.pub2. Cochrane Database Syst Rev. 2017. PMID: 28470696 Free PMC article.
References
-
- Schmitz T, Harmel E, Raake PP, et al. Association between acute myocardial infarction symptoms and short- and long-term mortality after the event. Can J Cardiol. 2024;40(7):1355–66. 10.1016/j.cjca.2024.01.019. PMID: 38278322. - PubMed
-
- Body R, Carley S, Wibberley C, et al. The value of symptoms and signs in the emergent diagnosis of acute coronary syndromes. Resuscitation. 2010;81(3):281–6. 10.1016/j.resuscitation.2009.11.014. PMID: 20036454. - PubMed
-
- Collet JP, Thiele H, Barbato E, ESC Scientific Document Group, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289–367. 10.1093/eurheartj/ehaa575. Erratum in: Eur Heart J. 2021 May 14;42(19):1908. 10.1093/eurheartj/ehad879. PMID: 32860058. - PubMed
-
- Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2017;39(2):119–77. 10.1093/eurheartj/ehx393. PMID: 28886621. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous